QP 24 - Bio 6: Immunotherapy and Immune Response II

Moderator(s)

• 

  Lisa Sudmeier, MD, PhD

  Winship Cancer Institute of Emory University
  Atlanta, GA
• 

  Stephen Shiao, MD, PhD

  Cedars-Sinai Medical Center
  Los Angeles, CA

Presentations:

• 10:30 AM – 10:35 AM ET

  Introduction
• 10:35 AM – 10:40 AM ET

  Impact of Aging on the Efficacy of Radiotherapy Combined with Immunotherapy and its Mechanism in a Mouse Model of Rectal Cancer
  

  Presenter: Yan Wang, MD, PhD – Fudan University Shanghai Cancer Center
• 10:40 AM – 10:45 AM ET

  Bcl-2 Inhibitor Combined with Radiotherapy and Anti-Tumor Immune Response through Inducing Immunogenic Cell Death
  

  Presenter: Mengmeng Ma, MD
• 10:45 AM – 10:50 AM ET

  Cross-Cancer Analysis Reveals Distinct Pattern of Immune Modulation during Curative Radiotherapy
  

  Presenter: Badr Id Said, MD, MS – MD Anderson Cancer Center
• 10:50 AM – 10:55 AM ET

  Perturbation of Gut Microbiota Modulated the Abscopal Effects of Immunoradiotherapy in Rectal Cancer.
  

  Presenter: Zhuang Xue, MD
• 10:55 AM – 11:00 AM ET

  TIGIT Inhibitor Combined with Local Radiotherapy and PD-1 Inhibitor in a Syngenic Breast Cancer Model
  

  Presenter: In Ah Kim, MD, PhD – Seoul National University
• 11:00 AM – 11:05 AM ET

  Macrophages Play Key Role in Protecting Salivary Glands from Radiation Induced Damage
  

  Presenter: Randall Kimple, MD, PhD, MBA, FASTRO – Univ of Wisconsin
• 11:05 AM – 11:25 AM ET

  Questions and Answers
• 11:25 AM – 11:30 AM ET

  Closing